New York, NY (December 10, 2022) — A new therapy that forces the immune system to kill bone marrow cancer cells has been successful in up to 73% of patients in two clinical trials, according to researchers from the Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai. The therapy, known as …
Experimental Cancer Therapy Shows Over 70% Patient Success in Global Clinical Trials Read More »
The coronavirus has been a sneaky enemy, with new variants and sub-variants rapidly evolving to evade vaccines and treatments. Researchers at Boston’s Dana-Farber Cancer Institute are working on an experimental drug that takes one of the virus’s most dangerous traits – its talent for mutation – and turns it against itself. When the coronavirus binds …
Experimental decoy drug tricks coronavirus, then destroys it Read More »
The experimental drug lecanemab showed a 27% slowing of the progression of cognitive decline in patients with early-stage Alzheimer’s disease, according to a study published this week in the New England Journal of Medicine. “These results show that lecanemab shows promise for people with early-stage Alzheimer’s disease, with a significant slowing of decline and a …
Experimental Alzheimer’s drug may slow disease progression, but there are risks: experts Read More »
Above is a red AIDS awareness ribbon.Image: Shutterstock (Shutterstock) An experimental HIV vaccine appears to have passed its first human test. In a recently published study, the vaccine candidate produced the kind of immune response scientists had hoped for in 97% of recipients. Importantly, the vaccine also appeared to be safe and well tolerated. The …
Experimental HIV vaccine shows promise in first-in-human trial Read More »
